Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

212 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Preventing ovarian hyperstimulation syndrome: guidance for the clinician.
Humaidan P, Quartarolo J, Papanikolaou EG. Humaidan P, et al. Fertil Steril. 2010 Jul;94(2):389-400. doi: 10.1016/j.fertnstert.2010.03.028. Epub 2010 Apr 22. Fertil Steril. 2010. PMID: 20416867 Review.
Ovarian response and pregnancy outcome related to mid-follicular LH levels in women undergoing assisted reproduction with GnRH agonist down-regulation and recombinant FSH stimulation.
Humaidan P, Bungum L, Bungum M, Andersen CY. Humaidan P, et al. Hum Reprod. 2002 Aug;17(8):2016-21. doi: 10.1093/humrep/17.8.2016. Hum Reprod. 2002. PMID: 12151430
The total consumption of exogenous FSH and duration of gonadotrophin stimulation was inversely related to LH levels on day 8 (P < 0.002). ...
The total consumption of exogenous FSH and duration of gonadotrophin stimulation was inversely related to LH levels on day 8 (P < …
Effects of recombinant LH supplementation in women undergoing assisted reproduction with GnRH agonist down-regulation and stimulation with recombinant FSH: an opening study.
Humaidan P, Bungum M, Bungum L, Yding Andersen C. Humaidan P, et al. Reprod Biomed Online. 2004 Jun;8(6):635-43. doi: 10.1016/s1472-6483(10)61643-4. Reprod Biomed Online. 2004. PMID: 15169576 Clinical Trial.
GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study.
Humaidan P, Bredkjaer HE, Bungum L, Bungum M, Grøndahl ML, Westergaard L, Andersen CY. Humaidan P, et al. Hum Reprod. 2005 May;20(5):1213-20. doi: 10.1093/humrep/deh765. Epub 2005 Mar 10. Hum Reprod. 2005. PMID: 15760966 Clinical Trial.

Significantly more metaphase II (MII) oocytes were retrieved in the GnRH agonist group (P < 0.02). Significantly higher levels of LH and FSH (P < 0.001) and significantly lower levels of progesterone and estradiol (P < 0.001) were seen in the GnRH ag

Significantly more metaphase II (MII) oocytes were retrieved in the GnRH agonist group (P < 0.02). Significantly higher levels of

Reproductive outcome using a GnRH antagonist (cetrorelix) for luteolysis and follicular synchronization in poor responder IVF/ICSI patients treated with a flexible GnRH antagonist protocol.
Humaidan P, Bungum L, Bungum M, Hald F, Agerholm I, Blaabjerg J, Yding Andersen C, Lindenberg S. Humaidan P, et al. Reprod Biomed Online. 2005 Dec;11(6):679-84. doi: 10.1016/s1472-6483(10)61685-9. Reprod Biomed Online. 2005. PMID: 16417730 Clinical Trial.
The results showed significantly more follicles (5.4 versus 3.5), oocytes (4.3 versus 2.4) and transferable embryos (1.8 versus 0.8) with the CRASH protocol as compared with the preceding long protocol (P < 0.005 in all cases). ...
The results showed significantly more follicles (5.4 versus 3.5), oocytes (4.3 versus 2.4) and transferable embryos (1.8 versus 0.8) with th …
To add or not to add LH: comments on a recent commentary.
Humaidan P. Humaidan P. Reprod Biomed Online. 2006 Mar;12(3):284-5. doi: 10.1016/s1472-6483(10)60998-4. Reprod Biomed Online. 2006. PMID: 16569311
Hormonal characteristics of follicular fluid from women receiving either GnRH agonist or hCG for ovulation induction.
Andersen CY, Humaidan P, Ejdrup HB, Bungum L, Grøndahl ML, Westergaard LG. Andersen CY, et al. Hum Reprod. 2006 Aug;21(8):2126-30. doi: 10.1093/humrep/del119. Epub 2006 May 8. Hum Reprod. 2006. PMID: 16682403

RESULTS: Follicular fluid levels of LH in the agonist group as compared with the hCG group was 11.1 +/- 0.5 versus 3.6 +/- 0.3 IU/l (mean +/- SEM; P < 0.001); FSH, 6.3 +/- 0.6 versus 3.3 +/- 0.2 IU/l (P < 0.001); hCG, not determined versus 139+/-8 IU/l; E(2),

RESULTS: Follicular fluid levels of LH in the agonist group as compared with the hCG group was 11.1 +/- 0.5 versus 3.6 +/- 0.3 IU/l (mean +/ …
Pain relief during oocyte retrieval--exploring the role of different frequencies of electro-acupuncture.
Humaidan P, Brock K, Bungum L, Stener-Victorin E. Humaidan P, et al. Reprod Biomed Online. 2006 Jul;13(1):120-5. doi: 10.1016/s1472-6483(10)62025-1. Reprod Biomed Online. 2006. PMID: 16820123 Clinical Trial.
In the fixed frequency group, however, a higher level of anxiety (P < 0.05) before oocyte retrieval was seen, and a higher level of nausea after aspiration of one ovary (P < 0.01) was seen in the mixed frequency group. ...

In the fixed frequency group, however, a higher level of anxiety (P < 0.05) before oocyte retrieval was seen, and a higher level o

Rescue of corpus luteum function with peri-ovulatory HCG supplementation in IVF/ICSI GnRH antagonist cycles in which ovulation was triggered with a GnRH agonist: a pilot study.
Humaidan P, Bungum L, Bungum M, Yding Andersen C. Humaidan P, et al. Reprod Biomed Online. 2006 Aug;13(2):173-8. doi: 10.1016/s1472-6483(10)60612-8. Reprod Biomed Online. 2006. PMID: 16895629 Clinical Trial.
Group 1 and group 3 had significantly higher luteal phase concentrations of progesterone (P < 0.001) as compared with group 2. Moreover, the clinical pregnancy rate of groups 1 and 3 was similar and significantly higher (P < 0.02) than that of group 2. ...

Group 1 and group 3 had significantly higher luteal phase concentrations of progesterone (P < 0.001) as compared with group 2. Mor

Triggering of final oocyte maturation with gonadotropin-releasing hormone agonist or human chorionic gonadotropin. Live birth after frozen-thawed embryo replacement cycles.
Griesinger G, Kolibianakis EM, Papanikolaou EG, Diedrich K, Van Steirteghem A, Devroey P, Ejdrup Bredkjaer H, Humaidan P. Griesinger G, et al. Fertil Steril. 2007 Sep;88(3):616-21. doi: 10.1016/j.fertnstert.2006.12.006. Epub 2007 Apr 23. Fertil Steril. 2007. PMID: 17451691
212 results
Jump to page
Feedback